Skip to main content

Table 1 Demographics and clinical data of the HCV-infected individuals enrolled in the current study

From: Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients

Characteristics

HCV chronic infection(n = 19)(Median (IQR1-IQR3))

Age (years)

51(40-58)

Gender(Male/Female)

12/7

HCV RNA(log 10 IU/ml)

6.14(5.76-6.56)

HCV Antibodies (S/CO ratio)

14.73(13.64-15.48)

HCV Antigens(log 10 fmol/L)

3.13(2.84-3.51)

Genotype(1b/2a)

6/13

CD4 + T cell count/μL

716(477-950)

CD8 + T cell count/μL

479(412-686)

ALT a level(IU/mL)

36(26-50)

AST b level(IU/mL)

36(32-48)

γGT c level(IU/mL)

19(17-32)

ALP d level(IU/mL)

65(56-81)

Albumin level(g/L)

43.70(41.60-47.20)

Total protein level(g/L)

76.40(73.14-79.40)

Ratio of albumin to globulin

1.37(1.18-1.54)

Total bilirubin level(μmol/L)

13.19(11.00-15.96)

Direct bilirubin level (μmol/L)

4.41(3.25-5.47)

Hemoglobin(g/L)

143(131-147)

  1. a ALT, Alanine aminotransferase;
  2. b AST, Aspartate aminotransfearse;
  3. c γ - GT, γ - glutamyltransferase;
  4. dALP, Alkaline phosphatase.